Company / Operating Cash Flow per Share
Tandem Diabetes Care Operating Cash Flow per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow per Share
-$0.15
FY2025
5-year range
-$0.49 / $0.67
FY2021-FY2025
Trend
-139.7%
vs FY2024
Sector context
#143 of 161
Health Care
What the data says
Tandem Diabetes Care's operating cash flow per share of $-0.15 is lower than 89% of companies in the Health Care sector (FY2025). Operating Cash Flow per Share has fluctuated over the past 10 years, ranging from $-18.90 in FY2017 to $0.67 in FY2021.
Based on SEC 10-K filings.
-0.15 in FY2025.
Improved from $-0.49 to $-0.15 over the past 2 years.
Health Care sector context is included.
Operating Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 11% in Health CareTop 89% of 161This company -$0.15 Sector average $6.67
▼
-102.2% below sector average
Key checks
Key Insights
- In FY2025, operating cash flow per share decreased 139.7% year-over-year.
- Ranks #143 out of 161 companies in the Health Care sector.
- Peak operating cash flow per share was recorded in FY2021.
- Lowest operating cash flow per share in the period was in FY2017.
Company context
Key Data Points
- Altman Z-Score -0.32 (distress zone, below 1.8 threshold)
- Negative profit margin: -20.2%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$0.15 | -139.7% |
| FY2024 | $0.37 | +174.9% |
| FY2023 | -$0.49 | -227.6% |
| FY2022 | $0.39 | -42.5% |
| FY2021 | $0.67 | +580.0% |
| FY2020 | -$0.14 | +87.8% |
| FY2019 | -$1.15 | +81.0% |
| FY2018 | -$6.05 | +68.0% |
| FY2017 | -$18.90 | -834.5% |
| FY2016 | -$2.02 | +18.6% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026